Announcements Trials
Browse Landscape

Phase

Phase 1 14Phase 2 10Phase 3 9Phase NA 4Phase 1/2 4Phase 2/3 1

Status

Recruiting 2Terminated 1Completed 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

CNS 14Gastrointestinal 13Thoracic 11Sarcoma 9Breast 6Lymphoid 5Genitourinary 5Gynecologic 4Dermatologic 4Head & Neck 3Other hematologic neoplasm 2Tumor-Agnostic 1Plasma cell 1

Conditions

Uterine Cervical Neoplasms 2Neoplasms 1Locally Advanced Cervical Carcinoma 1Cervical Adenocarcinoma 1Carcinoma 1

Interventions

Carboplatin 66Paclitaxel 54pembrolizumab 49Cyclophosphamide 34Cisplatin 28Bevacizumab 26Nivolumab 21Gemcitabine 18fludarabine 17liposomal doxorubicin 15Topotecan 15aldesleukin 13Filgrastim 12olaparib 11Interleukin-2 11Docetaxel 11Peripheral Blood Stem Cell Transplantation 10durvalumab 9Taxes 9Specimen Handling 9Oxaliplatin 8fludarabine phosphate 7epacadostat 7Magnetic Resonance Spectroscopy 7Ipilimumab 7Injections 7rucaparib 6niraparib 6lenvatinib 6cemiplimab 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1/2 × Radiation × Gynecologic × Clear all
NCT06543576 2025-08-15

External Beam Radiation Therapy and Brachytherapy With Chemotherapy and Immunotherapy for the Treatment of Stage IVB Cervical Cancer

Jonsson Comprehensive Cancer Center

Phase 1/2 Recruiting
35 enrolled
Gynecologic

Cervical Adenocarcinoma

NCT06391190 2024-04-30

Concurrent Chemoradiotherapy Followed by PD-1 Inhibitor in Advanced Cervical Cancer

RenJi Hospital

Phase 1/2 Recruiting
20 enrolled
Gynecologic

Locally Advanced Cervical Carcinoma

NCT00510250 2015-07-27

A Phase I/II Study of Cisplatin and Radiation in Combination With Sorafenib in Cervical Cancer

University Health Network, Toronto

Phase 1/2 Completed
13 enrolled
Gynecologic

Carcinoma, Uterine Cervical Neoplasms, Neoplasms

NCT01194609 2014-05-09

A Pilot Study of Radiation-Immune Cell Combination Therapy in Cervical Cancer

Korea Cancer Center Hospital

Phase 1/2 Terminated
2 enrolled
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡